Onconic Therapeutics Inc Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Onconic Therapeutics Inc

Watchlist Manager

Watchlist

Price: 14 370 KRW -0.62% Market Closed

Market Cap: ₩652.5B

O	Onconic Therapeutics Inc KOSDAQ:476060	KR
W	Wajax Corp F:5WJ	CA
	Megawatt Lithium and Battery Metals Corp F:WR2	CA
	Lilium NV NASDAQ:LILM	DE
	Asia-Pacific Strategic Investments Ltd F:2HN	SG
	Southern Sun Ltd F:JK9	ZA
H	Himalaya Shipping Ltd OSE:HSHIP	BM
	Live Motion Games SA F:4YM	PL
F	First Bancorp of Indiana Inc OTC:FBPI	US
S	SpectraScience Inc OTC:SCIE	US
P	Piscines Desjoyaux SA XBER:DJX	FR
	East West Bancorp Inc NASDAQ:EWBC	US
F	Founder Holdings Ltd XBER:FOU1	HK
R	Replicel Life Sciences Inc F:P6P2	CA

Profitability Summary

Onconic Therapeutics Inc's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Low Gross Margin

Low 3Y Average Gross Margin

Healthy Operating Margin

21%

Sustainable 3Y Average Operating Margin

20%

Healthy Net Margin

30%

Sustainable 3Y Average Net Margin

28%

Exceptional Free Cash Flow Margin

20%

Strong 3Y Average Free Cash Flow Margin

11%

Exceptional ROE

34%

Exceptional 3Y Average ROE

26%

Exceptional ROIC

90%

Exceptional 3Y Average ROIC

75%

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.